Development of novel treatments in melanoma patients with BRAF mutations
IMpower150 update from ELCC: atezolizumab and bevacizumab improve survival
How to treat established neuropathy?
Melanoma advancements: immunotherapy in the adjuvant setting
Lung cancer screening trials: NELSON and NLST